Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults - United States, 2017
- 10 April 2020
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 69 (14), 393-398
- https://doi.org/10.15585/mmwr.mm6914a1
Abstract
What is already known about this topic? Prevalence of hypertension increases with increasing age and is higher among men than women and among non-Hispanic blacks than among other racial/ethnic groups; prevalence has been consistently higher in the Southeastern and Appalachian regions of the United States. What is added by this report? Analysis of 2017 Behavioral Risk Factor Surveillance System data found that approximately one third of U.S. adults reported having hypertension, and an estimated 75% of those reporting having hypertension reported using antihypertensive medication. The prevalence of these factors varied widely by state and was generally highest in the Southeastern and Appalachian states. What are the implications for public health practice? A multidisciplinary team-based strategy working to educate patients, maintain dialogue over time, and identify risk factors can provide intervention opportunities for better blood pressure control and could reduce disparities in hypertension awareness, treatment, and control across the United States.This publication has 5 references indexed in Scilit:
- Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults Aged ≥18 Years — United States, 2011–2015Morbidity and Mortality Weekly Report (MMWR), 2018
- Hypertension Prevalence and Control Among Adults: United States, 2015-2016.2017
- Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries — United States, 2014Morbidity and Mortality Weekly Report (MMWR), 2016
- Team-Based Hypertension Management to Improve Blood Pressure ControlJournal of Primary Care & Community Health, 2016
- Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors--United States, 2011.2011